Inspire Advisors, LLC Precigen, Inc. Transaction History

Inspire Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$1.27 - $2.26 $10,712 - $19,063	8,435 Added 21.83%	47,079 $0
Q3 2022 Nov 07, 2022	SELL	$1.41 - $2.79 $5,757 - $11,391	-4,083 Reduced 9.56%	38,644 $82,000
Q2 2022 Aug 10, 2022	BUY	$1.15 - $2.53 $29,964 - $65,921	26,056 Added 156.3%	42,727 $57,000
Q1 2022 Apr 21, 2022	BUY	$1.91 - $3.98 $31,841 - $66,350	16,671 New	16,671 $35,000
Q1 2021 Apr 30, 2021	SELL	$6.74 - $10.95 $30,282 - $49,198	-4,493 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.75 - $10.56 $16,848 - $47,446	4,493 New	4,493 $46,000

145

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $371M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Advisors, LLC with notifications on news.